Results 21 to 30 of about 26,096 (220)

ABCG2 Pharmacogenetics [PDF]

open access: yesClinical Cancer Research, 2004
Abstract Purpose: The ATP-binding cassette transporter ABCG2 (breast cancer resistance protein) is an efflux protein that plays a role in host detoxification of various xenobiotic substrates, including the irinotecan metabolite 7- ethyl-10-hydroxycamptothecin (SN-38).
Floris A. de Jong   +6 more
openaire   +2 more sources

Nilotinib concentration in cell lines and primary CD34+ chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters [PDF]

open access: yes, 2009
Imatinib mesylate and nilotinib are highly effective at eradicating the majority of chronic myeloid leukemia (CML) cells; however, neither agent induces apoptosis of primitive CML CD34<sup>+</sup> cells.
Holyoake, T.L.   +10 more
core   +2 more sources

The Inhibitor Ko143 Is Not Specific for ABCG2 [PDF]

open access: yesThe Journal of Pharmacology and Experimental Therapeutics, 2015
Imaging ATP-binding cassette (ABC) transporter activity in vivo with positron emission tomography requires both a substrate and a transporter inhibitor. However, for ABCG2, there is no inhibitor proven to be specific to that transporter alone at the blood-brain barrier.
Lora D, Weidner   +9 more
openaire   +2 more sources

ABCG2 Gene and ABCG2 Protein Expression in Colorectal Cancer—In Silico and Wet Analysis

open access: yesInternational Journal of Molecular Sciences, 2023
ABCG2 (ATP-binding cassette superfamily G member 2) is a cell membrane pump encoded by the ABCG2 gene. ABCG2 can protect cells against compounds initiating and/or intensifying neoplasia and is considered a marker of stem cells responsible for cancer growth, drug resistance and recurrence. Expression of the ABCG2 gene or its protein has been shown to be
Aleksandra Sałagacka-Kubiak   +5 more
openaire   +2 more sources

The Challenge of Exploiting ABCG2 in the Clinic [PDF]

open access: yesCurrent Pharmaceutical Biotechnology, 2011
ABCG2, or breast cancer resistance protein (BCRP), is an ATP-binding cassette half transporter that has been shown to transport a wide range of substrates including chemotherapeutics, antivirals, antibiotics and flavonoids. Given its wide range of substrates, much work has been dedicated to developing ABCG2 as a clinical target.
Robert W, Robey   +3 more
openaire   +2 more sources

ABCG2 transporter plays a key role in the biodistribution of melatonin and its main metabolites [PDF]

open access: yes, 2023
[EN] The ATP-binding cassette G2 (ABCG2) is an efflux transporter expressed in the apical membrane of cells from a large number of tissues, directly affecting bioavailability, tissue accumulation, and secretion into milk of both xenobiotics and ...
García‐Lino, Alba M.   +20 more
core   +1 more source

ABCG2 – a transporter for all seasons [PDF]

open access: yesFEBS Letters, 2004
The human ABCG2 (ABCP/MXR/BCRP) protein is a recently recognized ABC half‐transporter, which forms homodimers in the plasma membrane and actively extrudes a wide variety of chemically unrelated compounds from the cells. This protein protects our cells and tissues against various xenobiotics, with a crucial role in the intestine, liver, placenta, and ...
Sarkadi, Balázs   +3 more
openaire   +2 more sources

Molecular evolution of the ATP-binding cassette subfamily G member 2 gene subfamily and its paralogs in birds

open access: yesBMC Evolutionary Biology, 2020
Background ATP-binding cassette (ABC) transporters are involved in the active transportation of various endogenous or exogenous substances. Two ABCG2 gene subfamily members have been identified in birds.
Shengchao Ma   +9 more
doaj   +1 more source

The ABCG2 resistance network of glioblastoma [PDF]

open access: yesCell Cycle, 2009
Glioblastoma multiforme (GBM) is the most common and lethal primary brain tumor variant. It exhibits heterogeneity at both the morphologic and genetic levels, with a complex combination of somatic alterations rendering the tumor class difficult to adequately treat. The role of so-called "cancer stem-cells" (CSCs) in the resistance of high-grade gliomas
Anne-Marie, Bleau   +2 more
openaire   +2 more sources

Potent and selective ABCG2 inhibitors derived from tariquidar [PDF]

open access: yes, 2013
Three different classes of selective ABCG2 modulator (BCRP, breast cancer resistance protein) derived from the lead structure tariquidar have been prepared in this thesis.
Ochoa Puentes, Cristian
core   +1 more source

Home - About - Disclaimer - Privacy